American Cytogenetics Inc., a North Hollywood-based operator of cancer screening services, has filed an application with the Securities and Exchange Commission to offer 4.98 million shares of common stock at about 37 cents a share.
The funds from the sale will be used to finance acquisitions or pay for upgrading equipment, said Edward Young, president of American Cytogenetics.
